Ethicon, Gmbh

Mcneil-Ppc, Inc.

Mentor Worldwide LLC

Other

Johnson & Johnson Consumer Inc.

Bmc Industries, Inc.

Vybion, Inc.

Chenango Zero LLC

Nicklasson, Fredrik

Leo B Kriksunov

Robert J Tannhauser

Harry S Sowden

Julian A Quintero

Duan Li Ou

Frank J Bunick

Joseph R Luber

Krasimira Hristov

John Matonick

Christopher Szymczak

Christopher E Szymczak

Kevin Shaun Weadock

Yi-Lan Wang

Nir I Nativ

Clifford Dwyer

Christophe Vailhe

Ronni L Robinson

Jerome Riebman

Silvia Sihui Chen

Jen-Chi Chen

Marc Feinberg

Gregory E Koll

Julian QUintero

Naomi Furgiuele

Lamar Kirchhevel

Joshua Ghaim

Dennis D Jamiolkowski

Joseph Henry Contiliano

Sasa Andjelic

Sridevi N Dhanaraj

Ibraheem T Badejo

Edward J Roche

An-Min Jason Sung

Luis Alberto Davila

Anita M Falcon

Derek Harris

Shane A Lacy

Udo Werner Graf

Elena Wolfe

Kevin D Trangone

Aliya Z Omer

Roland Olsson

Charles J Scheib

Daniel J Smith

Robert Anthony Rousseau

John Mott Goodman

Jianxin Guo

Frank Richard Cichocki, Jr

Susanne Landgrebe

Xintian Ming

James A Fleming

Howard Scalzo

David W Wynn

Charles M Wetzel

Michael Hoffman

Kenneth Michael Keilman

Rudolph Cedro, Jr

Marc Wisnudel

Katarina Lindell

Aliya Omer

Lee Alan Henderson

Craig Clay Eshleman

Oliver Dick

Matthew Pfefferkorn

Constantinos G Vayenas

Thomas C Weindl

Randall Eugene McCoy

Kevin Hengst

Geoffrey Wheelock

Jonathan Frenzel

Jerry Yan

Joseph Matton

Krasmira Hristov

Thomas R Sage

Lance Benjamin

John Mattson

Rolland Olsson

John Hendenstrom

John P Matonick

Andreas Hugerth

Fredrik Nicklasson

Howard Scalzo, Jr

The present invention is directed to an implantable medical device, comprising: a device body, with at least a portion of said body coated by a sensing coating that comprises an echogenic material or a radiopaque material, or combinations thereof, said sensing coating configured to dissolve or swell in presence of at least one infection biomarker; wherein a portion of said sensing coating is covered by a protective film, forming a protected portion, said protected portion configured not to dissolve or swell in presence of said biomarker and methods of detecting presence of biomarkers in the vicinity of an implanted medical device.

Sutures with coatings for detecting and reporting tissue infection

The present invention relates to a hemostatic absorbable composition, comprising: a flowable plurality of separate aggregates each comprising: a plurality of absorbable carrier particles coated on a surface thereof by a plurality of smaller particles comprising an absorbable supplemental hemostasis-promoting agent. In some embodiments, the absorbable carrier particles comprise gelatin or collagen, and the supplemental hemostasis-promoting agent comprises oxidized cellulose, oxidized regenerated cellulose, carboxylic oxidized cellulose, carboxylic oxidized regenerated cellulose, thrombin, or tranexamic acid.

Hemostatic composite aggregate materials having surface enriched with hemostatis-promoting agents

A reinforcing incision drape for tissue, such as fragile tissue, includes an absorbable surgical mesh having top and bottom major surfaces. The absorbable surgical mesh has a stitching zone and first and second reinforcing zones that bound opposite sides of the stitching zone. The stitching zone is less porous and the first and second reinforcing zones are more porous than the stitching zone. A releasable liner covers the top major surface of the absorbable surgical mesh within the stitching zone of the absorbable surgical mesh. A weaker adhesive, such as a pressure sensitive adhesive, covers the bottom major surface of the surgical mesh within the centrally located stitching zone of the absorbable surgical mesh, and a stronger adhesive, such as cyanoacrylite, covers the first and second reinforcing zones of the absorbable surgical mesh.

Reinforcing incision drapes having stitching zones bounded by reinforcing zones for closing incisions formed in fragile tissue

An implant delivery sleeve is disclosed. The sleeve may comprise a first tube including a first segment, a second segment, and a third segment. The first segment may have a first stiffness, the second segment may have a second stiffness, and the third segment may have a third stiffness. The third stiffness may be greater than the second stiffness and the second stiffness may be greater than the first stiffness. The implant-delivery sleeve may be used to deliver a breast implant to a subject. The implant may be deformed within the sleeve, to advance it within the sleeve and extrude it from the distal end of the sleeve.

Delivery sleeve

The present invention is directed to a length adaptive surgical suture comprising a monofilament or a braid of a plurality of filaments, the suture having an original length when implanted and a second length that is different from the original length within a first twenty-four (24) hour period of time after implantation to accommodate tissue swelling. The present invention is also directed to configurations and combinations that enable length adaptive results.

Adaptive sutures dynamically changing wound holding properties post-implantation

An implant delivery sleeve comprises a tubular wall having a proximal end with a proximal opening, a distal end with a distal opening, and an implant delivery channel extending between the proximal and distal ends of said tubular wall. A plurality of bands interconnect portions of the tubular wall for constricting the implant delivery channel adjacent the distal end of the tubular wall. As an implant is advanced toward the distal end of the tubular wall, the constriction squeezes and/or deforms the implant for facilitating insertion into an incision that is smaller than the normal size of the implant.

Implant delivery sleeves having non-tapered tubular walls with constricted implant delivery channels for inserting implants into tissue pockets

A reconfigurable suture needle includes an elongated body having a curved proximal section and a curved distal section. The curved proximal section is hollow and includes an elongated conduit extending from a proximal end to a distal end thereof. The curved distal section includes a needle point at a distal end thereof and a hollow post projecting proximally from a proximal end thereof. A suture thread passes through the elongated conduit of the curved proximal section and has a distal end that passes through the hollow post of the curved distal section for being secured to the proximal end of the curved distal section. The elongated body has a first configuration with a higher profile in which the hollow post of the curved distal section is inserted into the elongated conduit at the distal end of the curved proximal section, and a second configuration with a lower profile in which the hollow post of the curved distal section is uncoupled from the elongated conduit at the distal end of the curved proximal section.

Reconfigurable suture needles being transformable between higher profile configurations and lower profile configurations

A device for joining two layers of tissue, comprises a substantially flat and flexible scaffold having an upper surface, a lower surface and sidewalls; a plurality of first passages penetrating said scaffold from said upper surface to said lower surface; a plurality of second passages penetrating said scaffold from said upper surface to said lower surface; a substantially flat and flexible top cover releasably attached to said upper surface and covering all of said upper surface; said top cover having a plurality of top cover passages aligned with said first plurality of passages.

Scaffolds for joining layers of tissue at discrete points

A device for application onto incisions or wounds with a liquid rapidly polymerizable adhesive for forming skin closure systems, comprising a flat porous mesh elongated along a longitudinal axis and having an upper side and an opposing lower or wound facing side and a central portion in immediate vicinity of the axis; further having a plurality of pores and windows in said mesh, said windows substantially larger than said pores and arranged along said longitudinal axis in said central portion; a crosslinking or polymerization accelerator or initiator disposed in or on said mesh; and a pressure sensitive adhesive disposed on at least a portion of the lower surface of said mesh.

Skin closure devices with interrupted closure

The present invention is directed to a variable length applicator system for delivery of at least one medically useful liquid, comprising an elongated, telescopically extendable, variable length cannula having a liquid pump containing said liquid connected to said cannula at a proximal end, and a spray nozzle mounted on said cannula at a distal end; a coiled and extendable tubular conduit connected to and in fluid communication with, both said liquid pump and said spray nozzle; wherein an axial extension of said cannula is configured to cause a matching axial extension of said coiled tubular conduit.

Variable length telescoping application tips for flowable hemostats and sealants application

A delivery sleeve for assisting delivery of a tissue implant may include an enclosure an orifice, and a throat. A cinching mechanism, which may include a fastener, may be disposed about the throat. The fastener may be used to fasten the cinching mechanism in a cinched configuration to maintain the throat in a closed configuration. The cinching mechanism may include implant-size indicators thereon. A lubricant or lubricious material may be included upon an inner surface of the enclosure. The cinching mechanism may be used to change the configuration of the throat from an open configuration to a closed configuration. The fastener helps maintain the throat in a closed configuration.

The present is directed to systems for ex vivo testing performance of a hemostatic or sealing product attached to an animal organ and fully covering a cored channel in said organ, comprising: a pressure sensor positioned proximate to said hemostatic or sealing product in said cored channel; a monitoring or recording device configured to receive pressure readings from said pressure sensor; and a pressurized fluid source connected to said cored channel and configured to supply said pressurized fluid into said cored channel under constant or variable pressure. The present invention is also directed to methods of use for such systems.

Ex vivo and in vivo systems for evaluating hemostatic patches, sealants, adhesives on solid organs

The present invention is directed to a hemostatic semi-solid paste material comprising a bioabsorbable carrier hemostatic material; and a supplemental hemostatic agent; wherein the paste material has an elongated form extending along a lengthwise axis with an aspect ratio of at least 3; wherein the paste is self-supporting and syringe extrudable; and wherein the supplemental hemostatic agent has a non-homogenous distribution profile across a cross-section taken across the lengthwise axis. In another aspect, the present invention relates to devices for forming and expressing the hemostatic material.

Hemostatic paste having surface enriched with hemostasis-promoting agents and devices for delivery

A system or device for skin closure comprises an elastic flat flexible tape elongated along a longitudinal axis and having a lower side and an opposing upper side, said tape having a pressure sensitive adhesive on at least a portion of the lower side, said tape having a plurality of openings arranged side-by-side with spaces between said openings oriented across the longitudinal axis.

Skin closure systems and devices of improved flexibility and stretchability for bendable joints

A method of making an implantable prosthesis includes applying a gelling enhancer layer over an inner surface of a wall of a silicone shell having anterior and posterior walls surrounding an interior volume. The method includes filling the interior volume of the shell with a silicone gel and curing the silicone gel. The cured silicone gel that is located within a zone that is in the vicinity of the gelling enhancer layer has a higher level of cohesiveness than the cured silicone gel that is located outside the zone. The zone of the silicone gel having the higher level of cohesiveness has a thickness of 2-10 mm. The silicone gel located outside the zone has a first concentration level of a gelling enhancer and the silicone gel located within the zone has a second concentration level of the gelling enhancer that is 5%-300% greater than the first concentration level.

Methods of making implants having gel zones with higher levels of cohesiveness for eschewing scalloping, dimpling, and wrinkling

Growing community of inventors

Ithaca, NJ, United States of America

Leo B Kriksunov